Pancreatic Cancer Research

ResearcherAnhui Medical UniversityNo recent work listed

Longjiang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0475-2002; OpenAlex author ID A5052214038. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2013: 5 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 8

  1. CASC9 potentiates gemcitabine resistance in pancreatic cancer by reciprocally activating NRF2 and the NF-κB signaling pathway. First author DOI 10.1007/s10565-022-09746-w↗
  2. Upregulation of B3GNT3 Correlates With Poor Prognosis and Decreased Immune Cell Infiltration In Pancreatic Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-218028/v1↗
  3. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. Co-author PMID 25331466↗
  4. Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00432-013-1422-4↗
  5. Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s12032-013-0583-y↗
  6. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycopr… Co-author DOI 10.1016/j.pan.2013.03.010↗
  7. Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer. Co-author DOI 10.3892/ol.2013.1326↗
  8. [Analysis of pancreatic cancer peripheral blood by comparative proteomics]. Co-author PMID 23578431↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ren-bao Yang · 6 shared papers, 2013–2014 · strength 0.23
  2. Jiong Chen · 6 shared papers, 2013–2014 · strength 0.23
  3. Liwei Hu · 6 shared papers, 2013–2014 · strength 0.23
  4. Zhi‐Gang Tang · 1 shared paper, 2023 · strength 0.20
  5. Hanjun Li · 1 shared paper, 2023 · strength 0.20
  6. Zhengle Zhang · 1 shared paper, 2023 · strength 0.20
  7. Jing Tao · 1 shared paper, 2023 · strength 0.20
  8. Weibo Li · 1 shared paper, 2021 · strength 0.14
  9. Lichao Yao · 1 shared paper, 2021 · strength 0.14
  10. Lun Wu · 1 shared paper, 2021 · strength 0.14
  11. Lulu Zhai · 1 shared paper, 2021 · strength 0.14
  12. Zhi‐Gang Tang · 1 shared paper, 2021 · strength 0.14
  13. Yue Zhao · 3 shared papers, 2013–2014 · strength 0.12
  14. Yue Zhao · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.